Howe & Rusling’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-45
Closed 451
2022
Q3
$0 Sell
45
-179
-80% -$2.27K ﹤0.01% 1076
2022
Q2
$3K Sell
224
-40
-15% -$598 ﹤0.01% 766
2022
Q1
$4K Buy
264
+28
+12% +$464 ﹤0.01% 704
2021
Q4
$6K Buy
236
+44
+23% +$1.02K ﹤0.01% 615
2021
Q3
$4K Hold
192
﹤0.01% 689
2021
Q2
$5K Buy
192
+19
+11% +$522 ﹤0.01% 605
2021
Q1
$5K Buy
173
+12
+7% +$328 ﹤0.01% 606
2020
Q4
$5K Buy
161
+52
+48% +$1.54K ﹤0.01% 597
2020
Q3
$3K Buy
+109
New +$2.95K ﹤0.01% 635

Other funds holding CLVT

Howe & Rusling's CLVT Position: Q4 2022 in Review

Howe & Rusling sold out of Clarivate (CLVT) in Q4 2022, closing a stake of 45 shares.

Howe & Rusling first reported a position in CLVT in Q3 2020 and held it in 9 quarters. The position peaked at $6K in Q4 2021. 289 funds tracked by Wall St. Rank hold CLVT as of Q4 2022.

  • Howe & Rusling reported no remaining Clarivate position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 45 Clarivate shares in Q4 2022.
  • Howe & Rusling first reported a position in Clarivate in Q3 2020 and held it in 9 quarters.
  • Howe & Rusling's Clarivate position peaked at $6K in Q4 2021.
  • 289 funds tracked by Wall St. Rank held Clarivate as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.